Souhaitez-vous accéder aux communiqués récents ?

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a...

Initial clinical data for CLN-978 in SLE and RA confirmed for Q2 2026; repeat dosing data in RA confirmed for Q3 2026 Zipalertinib rolling NDA submission completed; enrollment of REZILIENT3 frontline...

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus...

Indemnity insurance for medical expenses covered 70% of Americans by 1960. Federal government is progressively taking over. Physician stewardship is needed

BALA CYNWYD, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...

BALA CYNWYD, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...

BENSALEM, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

Auddia Showcases Discovr Radio at 2026 SXSW with Live Demo Listening Events and Brand Activation within the Artist Lounge

Hyderabad, India, March 09, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the pharmaceutical packaging market size is projected to grow from USD 154.78 billion in 2025 to USD 163.99...

New York City, NY, March 08, 2026 (GLOBE NEWSWIRE) -- Memopezil is at the center of a rapidly growing conversation about cognitive health in 2026, as consumer interest in brain support has...